Loading...

Zoetis Inc.

ZTS•NYSE
Healthcare
Drug Manufacturers - Specialty & Generic
$116.87
$0.81(0.70%)
U.S. Market opens in NaNh NaNm

Zoetis Inc. (ZTS) Stock Overview

Explore Zoetis Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap49.3B
P/E Ratio19.15
EPS (TTM)$6.02
ROE0.58%
Fundamental Analysis

AI Price Forecasts

1 Month$106.30
3 Months$115.49
1 Year Target$134.67

ZTS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Zoetis Inc. (ZTS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 43.93, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $134.67.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 19.15 and a market capitalization of 49.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.66%
5-Day Change
-2.71%
1-Month Change
0.78%
3-Month Change
-5.82%
6-Month Change
-19.95%
Year-to-Date (YTD) Change
-7.15%
1-Year Change
-23.29%
3-Year Change
-33.75%
5-Year Change
-31.20%
All-Time (Max) Change
276.75%

Contact Information

https://www.zoetis.com
973 822 7000
10 Sylvan Way, Parsippany, NJ, 07054

Company Facts

13,800 Employees
IPO DateFeb 1, 2013
CountryUS
Actively Trading

Frequently Asked Questions